EBV DNA polymerase processivity factor BMRF1 208-216, TLDYKPLSV
Description
About EBV DNA polymerase processivity factor BMRF1 208-216, TLDYKPLSV
The Epstein-Barr Virus (EBV) (strain AG876) DNA polymerase processivity factor BMRF1 Peptide (IEDB: 64763) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The DNA polymerase processivity factor BMRF1 Peptide, H-TLDYKPLSV-OH (Uniprot: P0C6Z0 aa: 208-216) from JPT is produced under strict quality control and quality management.
EBV DNA polymerase processivity factor BMRF1 208-216, TLDYKPLSV - Specifications
- Peptide sequence: H-TLDYKPLSV-OH
- Amount: 10 mg (10 x 1 mg)
- Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
- Counterion: TFA
- Delivery Format: Freeze-dried in glass vial
- Application(s): T-cell Immunity
- Condition(s)/Topic(s): Infection, Infectious mononucleosis
- Standard Delivery Time: approx. 3 weeks
JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Take a look at our Custom Peptide Synthesis!
Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!
References
References for EBV DNA polymerase processivity factor BMRF1 208-216, TLDYKPLSV
References:
Read References with JPT’s Antigen Peptides
EBV DNA polymerase processivity factor BMRF1 208-216, TLDYKPLSV has been described in:
CD8+ immunodominance among Epstein-Barr virus lytic cycle antigens directly reflects the efficiency of antigen presentation in lytically infected cells., J Exp Med, 2005 (PMID: 15684323)
Epitope-specific evolution of human CD8(+) T cell responses from primary to persistent phases of Epstein-Barr virus infection., J Exp Med, 2002 (PMID: 11927633)
Characterization of the Canine MHC Class I DLA-88*50101 Peptide Binding Motif as a Prerequisite for Canine T Cell Immunotherapy., PLoS One, 2016 (PMID: 27893789)
Documentation
Documentation for EBV DNA polymerase processivity factor BMRF1 208-216, TLDYKPLSV
Properties
Properties of EBV DNA polymerase processivity factor BMRF1 208-216, TLDYKPLSV
Properties | Values |
---|---|
Application: | T-cell immunity |
Category: | Antigen Peptides |
Condition / Topic: | Infection, Infectious mononucleosis |
Layout: | Freeze-dried in glass vial |
Organism: | Epstein-Barr Virus (EBV) |
Protein Name: | DNA polymerase processivity factor BMRF1 |
Purity: | Trial Grade: each peptide purified to > 90% (HPLC/MS) |
Quantification: | No, Yes |
Further Information to EBV DNA polymerase processivity factor BMRF1 208-216, TLDYKPLSV
Information | Values |
---|---|
Sequence: | H-TLDYKPLSV-OH |
Specifications: | 9mer peptide as TFA salt |